Published within
| Type |
Product title / description
|
Pub
|
Price |
Report
|
An overview of M&A trends for the top 150 global pharmaceutical companies during 2008 and 2009 with discussion of the drivers of recent deals, plus case study analysis of key M&As.
Published By Datamonitor
|
17 Dec 2009 |
$11400
|
Report
|
Biosimilars: China Update provides analysis on the Chinese biogenerics market. It includes an overview of drivers and resistors to biogeneric uptake, market access strategies, key biogeneric players and future development trends.
Published By Datamonitor
|
22 Sep 2011 |
$1900
|
Report
|
Overview of the Chinese pharmaceutical market including socioeconomic and demographic trends, regulatory issues, generics and biosimilars analysis and pharmaceutical company infrastructure analysis.
Published By Datamonitor
|
25 Nov 2010 |
$7600
|
Report
|
Datamonitor’s report Orphan Drug Trends provides an overview of orphan drug regulations in the major pharmaceutical markets, including pricing and reimbursement issues and an analysis of Big Pharma’s growing interest in orphan drugs.
Published By Datamonitor
|
25 Nov 2011 |
$5700
|
Report
|
An overview of key trends shaping the pharmaceutical industry today, as well as drivers and resistors that are set to play a central role in the future as companies look to increase sales and boost profitability.
Published By Datamonitor
|
17 Mar 2010 |
$11400
|
Report
|
Global analysis of socio-demographic and economic trends, rising healthcare costs, intensifying cost-containment and regulatory pressures, the patent cliff as well insight into the pharmaceutical industry’s strategic responses to drive profitability.
Published By Datamonitor
|
20 May 2011 |
$1900
|
Report
|
Comparative analysis of biosimilar drivers and resistors, key players, market access, pricing, and future launches across multiple markets including: the US, Japan, France, Germany, Italy, Spain, the UK, Australia, Brazil, Russia, India and China.
Published By Datamonitor
|
23 Feb 2011 |
$3800
|
Report
|
Analysis on the global generics market. It includes an overview of drivers and resistors to generic uptake, key generics players, and opportunities for the generics industry.
Published By Datamonitor
|
18 Apr 2011 |
$3800
|
Report
|
Analysis of healthcare expenditure, reforms, pricing and reimbursement and drug regulation across multiple markets including: the US, Japan, France, Germany, Italy, Spain, the UK, Australia, Brazil, Russia, India and China.
Published By Datamonitor
|
25 Mar 2011 |
$3800
|
Report
|
Overview of cost-cutting, M&A and R&D trends across multiple markets including: the US, Japan, France, Germany, Italy, Spain, the UK, Australia, Brazil, Russia, India and China.
Published By Datamonitor
|
31 Mar 2011 |
$3800
|
No help is available.
Reports and briefs contain analyst driven analysis and opinion covering a specific market or issue.
Business Insight reports are an objective source of data, analysis and market insight
Insight for technology vendors into customer trends and pain points from key business decision makers.
Butler Group's thought leadership, opinion, with end user case studies and product profiles for key vendors.
Butler Group's vendor ranking and assessment model groups vendors into Outperform, Perform, and Under-perform categories.
Butler Group's thought leadership, opinion, and best practice with technology audits, product comparisons and rankings.
Opinion and market commentary from Datamonitor's industry experts.
Company profiles deliver detailed insight into how companies are organized and function with SWOT analysis.
Company reports provide detailed company evaluations.
Opinion and market commentary from Datamonitor's industry experts.
Company reports provide detailed company evaluations.
Opinion and market commentary from Datamonitor's industry experts.
Opinion and market commentary from Datamonitor's industry experts.
Track industry events, markets, products, customers, prospects, competitors and partners
Country profiles presenting easy-to-digest summaries and standardized data.
Databooks use charts and tables to provide a data-centric view of a particular market or category
Opinion and market commentary from Datamonitor's industry experts.
Comprehensive category data, including market value, volume, segmentation and share, with analysis.
Industry profiles provide standardized market data (including size & segmentation) and competitive analysis.
Market sizing and forecast data for a market or sector delivered in spreadsheet format.
Track industry events, markets, products, customers, prospects, competitors and partners
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Reports and briefs contain analyst driven analysis and opinion covering a specific market or issue.
Opinion and market commentary from Datamonitor's industry experts.
Insight for technology vendors into customer trends and pain points from key business decision makers.
Business information covering a specific market or issue.